Literature DB >> 22250611

Prevalence and relation of dementia to various factors in Parkinson's disease.

Abdul Qayyum Rana1, Muhammad Saad Yousuf, Sughra Naz, Nour Qa'aty.   

Abstract

AIMS: Parkinson's disease is a chronic neurodegenerative disorder characterized by bradykinesia, rigidity, and resting tremor. Dementia, among its non-motor symptoms, is a debilitating complication affecting intellectual functioning. The aim of the present study was to determine the prevalence of dementia in Parkinson's disease and its relation to age, gender and stage of the disease.
METHODS: A retrospective chart analysis was performed on Parkinson's disease patients seen in a community-based Parkinson's disease and movement disorder clinic between 2005 and 2010.
RESULTS: A total of 310 patients were included in this survey, among whom 61 patients (19.7%) with Parkinson's disease met the criteria for dementia. Age was found to be a significant factor in developing dementia, with 90% of patients with dementia aged ≥70. Gender, however, was not correlated with dementia in Parkinson's disease. On analysis of stage at which dementia developed, progression of the disease was positively correlated with prevalence of dementia.
CONCLUSIONS: As age increases, the chances of developing dementia increase. Dementia, contrarily, is not selective between genders. The likelihood of developing dementia increases as the stage of disease advances. Further research is required in order to understand underlying mechanisms of dementia in Parkinson's disease.
© 2012 The Authors. Psychiatry and Clinical Neurosciences © 2012 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Year:  2012        PMID: 22250611     DOI: 10.1111/j.1440-1819.2011.02291.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease.

Authors:  Richard A Armstrong; Paul T Kotzbauer; Joel S Perlmutter; Meghan C Campbell; Kyle M Hurth; Robert E Schmidt; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2013-08-31       Impact factor: 3.575

2.  COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Authors:  Andreea Seritan; Jennifer Cogswell; Jim Grigsby
Journal:  Curr Psychiatry Rev       Date:  2013-02

3.  Sex Differences in Cognitive Changes in De Novo Parkinson's Disease.

Authors:  Ece Bayram; Sarah J Banks; Guogen Shan; Nikki Kaplan; Jessica Z K Caldwell
Journal:  J Int Neuropsychol Soc       Date:  2019-12-11       Impact factor: 2.892

4.  Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.

Authors:  Erika F Augustine; Adriana Pérez; Rohit Dhall; Chizoba C Umeh; Aleksandar Videnovic; Franca Cambi; Anne-Marie A Wills; Jordan J Elm; Richard M Zweig; Lisa M Shulman; Martha A Nance; Jacquelyn Bainbridge; Oksana Suchowersky
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

5.  Pimavanserin for Psychosis in Parkinson's Disease-Related Disorders: A Retrospective Chart Review.

Authors:  Jessie Sellers; R Ryan Darby; Alma Farooque; Daniel O Claassen
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 6.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.